TARRYTOWN, NY--Regeneron Pharmaceuticals here has named David Valenzuela to the position of vice-president of genomics and bioinformatics. He was previously Regeneron's senior director for genomics and bioinformatics. In addition, the company added the title of chief scientific officer to the position of George Yancopoulos, who remains the company's senior vice-president of research.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.